Crossmark

Primary tumor volume and prognosis for patients with p16-positive and p16-negative oropharyngeal squamous cell carcinoma treated with radiation therapy

Crossref DOI link: https://doi.org/10.1186/s13014-022-02074-7

Published Online: 2022-06-14

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Adrian, Gabriel

Carlsson, Henrik

Kjellén, Elisabeth

Sjövall, Johanna

Zackrisson, Björn

Nilsson, Per

Gebre-Medhin, Maria
Funding

Funding for this research was provided by:

Fru Berta Kamprads Stiftelse (FBKS 2020-19-301)

Lund University
License Information

Text and Data Mining valid from 2022-06-14

Version of Record valid from 2022-06-14
More Information

Article History

Received: 9 February 2022

Accepted: 27 May 2022

First Online: 14 June 2022

Declarations

:

: Ethical boards approved the three studies as previously described [, , ].

: Not applicable.

: The authors declare no competing interest.

Document is current

Any future updates will be listed below